Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 8 to 10 amino acid residues in defined sequence
Patent
1994-03-30
1995-12-05
Warden, Jill
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
8 to 10 amino acid residues in defined sequence
530327, A61K 3800, C07K 700, C07K 706, C07K 708
Patent
active
054730546
ABSTRACT:
Short peptides which function as analogs of IGF-1 are provided. These peptides abolish the proliferation of cells at nanogram concentrations. The peptides are non-toxic, and the inhibitor effect is reversible. The use of these peptides, because of their low toxicity and high efficiency, holds promises for treatment of a variety of human conditions, including prevention of restenosis of the coronary arteries after angioplasty, treatment of human neoplasia such as cancer of the prostate, treatment of tumors in pleural and peritoneal cavities and brain metastases, treatment of other abnormalities of cell growth in human beings, treatment of smooth muscle cell hyperplasia in asthma, treatment to promote burn and wound healing, and purging bone marrow from highly proliferating cells.
REFERENCES:
patent: 4699897 (1987-10-01), Jones et al.
patent: 4797469 (1989-01-01), Diaz et al.
patent: 4876242 (1989-10-01), Applebaum et al.
patent: 5070075 (1991-12-01), Rotwein et al.
patent: 5077276 (1991-12-01), Ballard et al.
patent: 5084555 (1992-01-01), Coy et al.
patent: 5093317 (1992-03-01), Lewis et al.
Bayne et al., "The C Region of Human Insulin-like Growth Factor (IGF) I Is Required for High Affinity Binding to the Type 1 IGF Receptor,", J. of Biol. Chem., 264:11004-11008, 1988.
Bodanszky et al., Peptide Synthesis, John Wiley & Sons, 2d Ed., 1976.
Cascieri et al., "Mutants of Human Insulin-like Growth Factor I with Reduced Affinity for the Type 1 Insulin-like Growth Factor Receptor," Biochemistry, 27:3229-3233, 1988.
Cascieri et al., Molecular and Cellular Biology of IGFs and Their Receptors, LeRoth et al., eds., Plenum Press: London, 1990.
Cooke et al., "Solution Structure of Human Insulin-like Growth Factor 1: A Nuclear Magnetic Resonance and Restrained Molecular Dynamics Study," Biochemistry 30:5484-5491, 1991.
Foekens et al., "Prognostic Value of Estrogen and Progesterone Receptors Measured by Enzyme Immunoassays in Human Breast Tumor Cytosols," Cancer Research, 49:5823-5828, 1989.
Gammeltoft et al., "Expression of Two Types of Receptor for Insulin-like Growth Factors in Human Malignant Glioma," Cancer Research, 48:1233-1237, 1988.
Goldring et al., "Cytokines and Cell Growth Control," Eucar. Gene Express, 1:301-326, 1991.
Hartmann et al., "Heterogeneity of Insulin and Insulin-like Growth Factor-I Binding in a Human Burkitt Type ALL Cell Line during the Cell Cycle in Three Burkitt Type ALL Sublines," Leukemia, 2:241-244, 1988.
Hizuka et al., "Characterization of Insulin-like Growth Factor I Receptors on Human Erythroleukemia Cell Line (K-562 Cells)," Endocrinol. Japan, 34:81-88, 1987.
Jameson, B. A., "Modelling in peptide design," Nature, 341:465-466, 1989.
Jansen et al., "Sequence of cDNA encoding human insulin-like growth factor I precursor," Nature, 306:609-611, 1983.
Jaques et al., "Production of Insulin-like Growth Factor Binding Proteins by Small-Cell Lung Cancer Cell Lines," Exp. Cancer Research, 184:396-406, 1989.
Kent et al., Synthetic Peptides in Biology and Medicine, Alitalo et al., eds., Elsevier Science Publishers: Amsterdam, pp. 295-358, 1985.
Kozak et al., "Type I and II Insulin-like Growth Factor Receptors on Human Phytohemagglutinin-Activated T Lymphocytes," Cellular Immunology, 109:318-331, 1987.
Lee et al., "Characterization of Insulin, Insulin-Like Growth Factors I and II, and Growth Hormone Receptors on Human Leukemic Lymphoblasts," J. Clin. Endocrinol. & Metabol., 62:28-35, 1986.
Massague et al., "The Subunit Structures of Two Distinct Receptors for Insulin-like Growth Factors I and II and Their Relationships to the Insulin Receptor," J. of Biol. Chem., 257:5038-5045, 1982.
McOmie, Protective Groups in Organic Chemistry, Plenum Press: New York, 1973.
Merrifield, R. B., "Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide," J. Am Chem. Soc., 85:2149-2154, 1963.
Minuto et al., "Evidence for Autocrine Mitogenic Stimulation by Somatomedin-C/Insulin-like Growth Factor I on an Established Human Lung Cancer Cell Line," Cancer Research, 48:3716-3719, 1988.
Nakanishi et al., "Insulin-like Growth Factor-I Can Mediate Autocrine Proliferation of Human Small Cell Lung Cancer Cell Lines in Vitro," J. Clin. Invest., 82:354-359, 1988.
Neurath et al., eds., The Proteins, vol. II, 3d Ed., Academic Press: New York, pp. 105-237, 1976.
Ota et al., "TPA-induced neurite formation in a neuroblastoma cell line (SH-SY5Y) is associated with increased IGF-I receptor mRNA and binding," Molec. Brain Res., 6:69-76, 1989.
Ota et al., "Insulin-like growth factor I receptors on mouse neuroblastoma cells," Cur. J. Biochem., 174:521-530, 1988.
Pekonen et al., "Receptors for Epidermal Growth Factor and Insulin-like Growth Factor I and Their Relation to Steroid Receptors in Human Breast Cancer," Cancer Research, 48:1343-1347, 1988.
Pekonen et al., "Binding of Epidermal Growth Factor I and Insulin-like Growth-Factor I in Renal Carcinoma and Adjacent Normal Kidney Tissue," Int. J. Cancer, 43:1029-1033, 1989.
Pepe et al., "Receptor Binding and Mitogenic Effects of Insulin and Insulinlike Growth Factors I and II for Human Myeloid Leukemic Cells," J. Cell Physiol., 133:219-227, 1987.
Peyrat et al., "Insulin-like Growth Factor I Receptors in Human Breast Cancer and Their Relation to Estradiol and Progesterone Receptors," Cancer Res., 48:6429-6433, 1988.
Rinderknecht et al., "The Amino Acid Sequence of Human Insulin-like Growth Factor I and Its Structural Homology with Proinsulin," J. Biol. Chem., 253:2769-2776, 1978.
Ritvos et al., "Characterization of Functional Type I Insulin-Like Growth Factor Receptors from Human Choriocarcinoma Cells," Endocrinology, 122:395-401, 1988.
Rotwein et al., "Organization and Sequence of the Human Insulin-like Growth Factor I Gene," J. Biol. Chem., 261:4828-4832, 1986.
Stewart et al., "Role of Insulin-like Growth Factors and the Type I Insulin-like Growth Factor Receptor in teh Estrogen-stimulated Proliferation of Human Breast Cancer Cells," J. Biol. Chem., 265:21172-21178, 1990.
Stracke et al., "The Type I Insulin-like Growth Factor Receptor Is a Motility Receptor in Human Melanoma Cells," J. Biol. Chem., 264:21544-21549, 1989.
Stuart et al., Solid Phase Peptide Synthelia, Pierce Chemical Company: Illinois, 1984.
Van Wyk et al., "Role of Somatomedin in Cellular Proliferation," The Biology of Human Growth, New York: Raven Press, 1981. pp. 223-239.
Werner et al., "Developmental regulation of the rat insulin-like growth factor I receptor gene," Proc. Natl. Acad. Sci. USA, 86:7451-7455, 1989.
Pietrzkowski et al., "Inhibition of Growth of Prostatic Cancer Cell Lines by Peptide Analogues of Insulin-like Growth Factor 1," Cancer Research, 53:1102-1106, 1993.
Pietrzkowski et al., "Inhibition of Cellular Proliferation by Peptide Analogues of Insulin-like Growth Factor 1," Cancer Research, 52:6447-6451, 1992.
Talavera et al., J. Cancer Res., 50:3019-24 (1990).
Baserga Renato
Jameson Bradford A.
Marshall S. G.
Thomas Jefferson University
Warden Jill
LandOfFree
IGF-1 analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with IGF-1 analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and IGF-1 analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1374965